Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
372.1000 -7.95 (-2.09%)
NSE Jul 07, 2025 15:31 PM
Volume: 3.3M
 

logo
Biocon Ltd.
13 Aug 2023
372.10
-2.09%
ICICI Securities Limited
Biocon’s Q1FY24 performance was dragged by the biologics biz. Profitability of the segment was under pressure owing higher rebates in Fulphila (USD 15mn). Segmental PBT dropped 600bps QoQ to 1.6% in Q1FY24. US market share of Fulphila and Ogivri expanded by 200bps and 100bps QoQ to 16% and 11%, and stable at 12% for bGlargine.
Biocon Ltd. has an average target of 389.25 from 4 brokers.
More from Biocon Ltd.
Recommended